Arena Pharmaceuticals and its board of directors were slapped with a shareholder lawsuit Friday in Pennsylvania Eastern District Court arising from the company's proposed $6.7 billion sale to Pfizer. The court action, brought by the Grabar Law Offices on behalf of Jeffrey D. Justice II, claims the defendants misrepresented Arena's financial projections to stockholders. Counsel have not yet appeared for the defendants. The case is 2:22-cv-00178, Justice, II v. Arena Pharmaceuticals, Inc. et al.